CC BY-NC-ND 4.0 · Am J Perinatol 2024; 41(S 01): e853-e862
DOI: 10.1055/a-1961-2059
Original Article

A Description of the Imaging Innovations for Placental Assessment in Response to Environmental Pollution Study

Carla Janzen*
1   Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Margarida Y. Y. Lei
1   Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Brian R. Lee
2   Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Sitaram Vangala
3   Department of Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Irish DelRosario
4   Department of Epidemiology, Jonathan Fielding School of Public Health at University of California Los Angeles, Los Angeles, California
,
Qi Meng
4   Department of Epidemiology, Jonathan Fielding School of Public Health at University of California Los Angeles, Los Angeles, California
,
Beate Ritz
4   Department of Epidemiology, Jonathan Fielding School of Public Health at University of California Los Angeles, Los Angeles, California
,
Jonathan Liu
5   Department of Environmental Health Sciences, Jonathan Fielding School of Public Health at University of California Los Angeles, Los Angeles, California
,
Michael Jerrett
5   Department of Environmental Health Sciences, Jonathan Fielding School of Public Health at University of California Los Angeles, Los Angeles, California
,
Teresa Chanlaw
2   Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Sarah Choi
2   Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Arya Aliabadi
3   Department of Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Precious Ann Fortes
6   Department of Pathology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Peggy S. Sullivan
6   Department of Pathology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Aisling Murphy
1   Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Giorgia Del Vecchio
2   Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Shanthie Thamotharan
2   Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
KyungHyun Sung*
7   Department of Radiology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
,
Sherin U. Devaskar*
2   Department of Pediatrics, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California
› Author Affiliations
Funding This work was supported by the NIH-U01 HD087221 (multi-PI to S.U.D., K.S., and C.J.) and NICHD HD089714 and HD100015 (to S.U.D.).

Abstract

Objective The aim of Placental Assessment in Response to Environmental Pollution Study (PARENTs) was to determine whether imaging of the placenta by novel multiparametric magnetic resonance imaging (MRI) techniques in early pregnancy could help predict adverse pregnancy outcomes (APOs) due to ischemic placental disease (IPD). Additionally, we sought to determine maternal characteristics and environmental risk factors that contribute to IPD and secondary APOs.

Study Design Potential patients in their first trimester of pregnancy, who agreed to MRI of the placenta and measures of assessment of environmental pollution, were recruited into PARENTs, a prospective population-based cohort study. Participants were seen at three study visits during pregnancy and again at their delivery from 2015 to 2019. We collected data from interviews, chart abstractions, and imaging. Maternal biospecimens (serum, plasma, and urine) at antepartum study visits and delivery specimens (placenta, cord, and maternal blood) were collected, processed, and stored. The primary outcome was a composite of IPD, which included any of the following: placental abruption, hypertensive disease of pregnancy, fetal growth restriction, or a newborn of small for gestational age.

Results In this pilot cohort, of the 190 patients who completed pregnancy to viable delivery, 50 (26%) developed IPD. Among demographic characteristics, having a history of prior IPD in multiparous women was associated with the development of IPD. In the multiple novel perfusion measurements taken of the in vivo placenta using MRI, decreased high placental blood flow (mL/100 g/min) in early pregnancy (between 14 and 16 weeks) was found to be significantly associated with the later development of IPD.

Conclusion Successful recruitment of the PARENTs prospective cohort demonstrated the feasibility and acceptability of the use of MRI in human pregnancy to study the placenta in vivo and at the same time collect environmental exposure data. Analysis is ongoing and we hope these methods will assist researchers in the design of prospective imaging studies of pregnancy.

Key Points

  • MRI was acceptable and feasible for the study of the human placenta in vivo.

  • Functional imaging of the placenta by MRI showed a significant decrease in high placental blood flow.

  • Measures of environmental exposures are further being analyzed to predict IPD.

* These authors are the equal contributors to the overarching study concept, design, methods, and execution of the study.




Publication History

Received: 20 April 2022

Accepted: 22 September 2022

Accepted Manuscript online:
14 October 2022

Article published online:
05 December 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Rich-Edwards JW, Fraser A, Lawlor DA, Catov JM. Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health?. Epidemiol Rev 2014; 36: 57-70
  • 2 Guttmacher AE, Spong CY. The Human Placenta Project: it's time for real time. Am J Obstet Gynecol 2015; 213 (4, suppl): S3-S5
  • 3 Guttmacher AE, Maddox YT, Spong CY. The Human Placenta Project: placental structure, development, and function in real time. Placenta 2014; 35 (05) 303-304
  • 4 Sadovsky Y, Clifton VL, Burton GJ. Invigorating placental research through the “Human Placenta Project”. Placenta 2014; 35 (08) 527
  • 5 Ananth CV. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction, and placental abruption. Semin Perinatol 2014; 38 (03) 131-132
  • 6 Ananth CV, Vintzileos AM. Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol 2006; 195 (06) 1557-1563
  • 7 Vintzileos AM, Ananth CV. First trimester prediction of ischemic placental disease. Semin Perinatol 2014; 38 (03) 159-166
  • 8 Brink HS, van der Lely AJ, van der Linden J. The potential role of biomarkers in predicting gestational diabetes. Endocr Connect 2016; 5 (05) R26-R34
  • 9 Liu D, Shao X, Danyalov A. et al. Human placenta blood flow during early gestation with pseudocontinuous arterial spin labeling MRI. J Magn Reson Imaging 2020; 51 (04) 1247-1257
  • 10 Bekkar B, Pacheco S, Basu R, DeNicola N. Association of air pollution and heat exposure with preterm birth, low birth weight, and stillbirth in the US: a systematic review. JAMA Netw Open 2020; 3 (06) e208243
  • 11 Su JG, Meng YY, Chen X, Molitor J, Yue D, Jerrett M. Predicting differential improvements in annual pollutant concentrations and exposures for regulatory policy assessment. Environ Int 2020; 143: 105942
  • 12 Zota A, Adamkiewicz G, Levy JI, Spengler JD. Ventilation in public housing: implications for indoor nitrogen dioxide concentrations. Indoor Air 2005; 15 (06) 393-401
  • 13 Poon LC, Shennan A, Hyett JA. et al. Erratum to “The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention” [Int J Gynecol Obstet 145 Suppl. 1 (2019) 1–33]. Int J Gynaecol Obstet 2019; 146 (03) 390-391
  • 14 Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18 (06) 583-586
  • 15 Shao X, Liu D, Martin T. et al. Measuring human placental blood flow with multidelay 3D GRASE pseudocontinuous arterial spin labeling at 3T. J Magn Reson Imaging 2018; 47 (06) 1667-1676
  • 16 Martin T, Janzen C, Li X. et al. Characterization of uterine motion in early gestation using MRI-based motion tracking. Diagnostics (Basel) 2020; 10 (10) E840
  • 17 Armstrong T, Liu D, Martin T. et al. 3D [formula: see text] mapping of the placenta during early gestation using free-breathing multiecho stack-of-radial MRI at 3T. J Magn Reson Imaging 2019; 49 (01) 291-303
  • 18 Khong TY, Mooney EE, Ariel I. et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group Consensus Statement. Arch Pathol Lab Med 2016; 140 (07) 698-713
  • 19 Hypertension in pregnancy. report of the American College of Obstetricians and Gynecologists' Task Force on hypertension in pregnancy. Obstet Gynecol 2013; 122 (05) 1122-1131
  • 20 American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. Female sexual dysfunction: ACOG Practice Bulletin Clinical Management Guidelines for Obstetrician-Gynecologists, Number 213. Obstet Gynecol 2019; 134 (01) e1-e18
  • 21 Committee on Practice B-O. ACOG Practice Bulletin No. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
  • 22 ACOG Practice Bulletin No. ACOG Practice Bulletin No. 227: fetal growth restriction: correction. Obstet Gynecol 2021; 137 (04) 754
  • 23 Gómez O, Figueras F, Martínez JM. et al. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 2006; 28 (06) 802-808
  • 24 Del Vecchio G, Li Q, Li W. et al. Cell-free DNA methylation and transcriptomic signature prediction of pregnancies with adverse outcomes. Epigenetics 2021; 16 (06) 642-661